Why a Branded Weight-Loss Pen Costs ₹16,000 in India When the Molecule Costs ₹1,500
The molecule is now commodity-cheap in India. So what is the branded price tag actually buying you?
ALTRcare Medical Team
Clinical Editorial
In the US, a month of branded semaglutide can cost over ₹85,000. In India, a branded Wegovy or Mounjaro pen runs roughly ₹11,000 to ₹26,000 a month depending on dose. And as of 2026, generic semaglutide from Indian manufacturers sells for as little as ₹1,300 to ₹4,000 a month. Same active molecule. The price gap is enormous. So what are you actually paying for?
The molecule is now cheap
Semaglutide's patent expired in India in early 2026, and domestic drugmakers moved fast — multiple generic injectable versions are now on the market at a fraction of branded prices. The chemistry inside a ₹16,000 branded pen and a ₹1,500 generic vial is, for practical purposes, the same drug.
So why the markup?
A branded pen bundles three things: the molecule, a slick auto-injector device, and years of global marketing and brand premium. The device is genuinely convenient. The brand is not medicine. For most patients, a large share of the branded price is paying for everything except the thing that makes you lose weight.
But a cheap molecule isn't safe weight loss
Here's the catch the price tag hides. Semaglutide isn't paracetamol. It needs the right starting dose, a careful titration schedule, screening before you begin, and someone managing side effects when they hit. Buying the cheapest vial off a pharmacy shelf and self-dosing is exactly how people end up nauseated, dehydrated, and quitting in week two — convinced the drug failed them, when really the plan did.
What you should actually pay for
The smart spend in 2026 isn't the brand on the pen — it's the doctor behind the protocol. A proper programme covers eligibility screening (especially important for Indians with a normal BMI but high visceral fat), the right molecule and dose, titration, side-effect management, and the nutrition support that prevents muscle loss.
That's how ALTRcare is built: the affordable generic molecule, plus the medical supervision that the cheap-vial route skips. You're not paying a brand tax — you're paying for it to be done safely. And if a calorie deficit alone has failed you, there may be a hormonal reason worth checking first.
Pay for the doctor, not the brand
Take the free 2-minute assessment. A doctor reviews it and prescribes the right molecule and dose — no brand mark-up.
Frequently asked questions
Is generic semaglutide as good as branded Ozempic or Wegovy?
The active molecule is the same. The differences are in the delivery device, brand, and — most importantly — whether you have medical supervision around dosing and side effects.
How much does semaglutide cost per month in India in 2026?
Branded pens broadly run ₹11,000–₹26,000 a month depending on the product and dose, while generic injectable semaglutide from Indian manufacturers can start around ₹1,300–₹4,000 a month for the molecule alone.
Why does a doctor-led programme cost more than the cheapest vial?
Because it includes the parts that make treatment work safely: screening, correct titration, side-effect management, and nutrition support to protect muscle. The cheapest vial includes none of that.
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed — no obligation.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
